{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:48:24Z","timestamp":1777391304886,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There were limited data on adipose and serum zinc alpha-2-glycoprotein (ZAG) expression and its association with body composition in patients with advanced chronic kidney disease (CKD). This study aimed to quantify adipose and serum ZAG expression and evaluate their association with body composition and its longitudinal change, together with mortality in incident dialysis patients. We performed a single-center prospective cohort study. Patients who were planned for peritoneal dialysis were recruited. ZAG levels were measured from serum sample, subcutaneous and pre-peritoneal fat tissue obtained during peritoneal dialysis catheter insertion. Body composition and functional state were evaluated by bioimpedance spectroscopy and Clinical Frailty Scale respectively at baseline and were repeated 1\u00a0year later. Primary outcome was 2-year survival. Secondary outcomes were longitudinal changes of body composition. At baseline, the average adipose and serum ZAG expression was 13.4\u2009\u00b1\u2009130.0-fold and 74.7\u2009\u00b1\u200920.9\u00a0\u00b5g\/ml respectively. Both adipose and serum ZAG expressions independently predicted adipose tissue mass (ATM) (p\u2009=\u20090.001, p\u2009=\u20090.008, respectively). At 1\u00a0year, ATM increased by 3.3\u2009\u00b1\u20097.4\u00a0kg (p\u2009&lt;\u20090.001) while lean tissue mass (LTM) remained similar (p\u2009=\u20090.5). Adipose but not serum ZAG level predicted change in ATM (p\u2009=\u20090.007) and LTM (p\u2009=\u20090.01). Serum ZAG level predicted overall survival (p\u2009=\u20090.005) and risk of infection-related death (p\u2009=\u20090.045) after adjusting for confounders. In conclusion, adipose and serum ZAG levels negatively correlated with adiposity and predicted its longitudinal change of fat and lean tissue mass, whilst serum ZAG predicted survival independent of body mass in advanced CKD patient.<\/jats:p>","DOI":"10.1038\/s41598-022-13149-6","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T17:02:58Z","timestamp":1654016578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Adipose and serum zinc alpha-2-glycoprotein (ZAG) expressions predict longitudinal change of adiposity, wasting and predict survival in dialysis patients"],"prefix":"10.1038","volume":"12","author":[{"given":"Gordon Chun-Kau","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Win Hlaing","family":"Than","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie Ching-Ha","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ka-Bik","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald Cheong-Kin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy Yuen-Chun","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack Kit-Chung","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Ming","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winston Wing-Shing","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis Mei-Shan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-Ching","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Bon","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip Kam-Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheuk-Chun","family":"Szeto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"issue":"11","key":"13149_CR1","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1017\/S0007114520000306","volume":"123","author":"S Law","year":"2020","unstructured":"Law, S. & Davenport, A. Glucose absorption from peritoneal dialysate is associated with a gain in fat mass and a reduction in lean body mass in prevalent peritoneal dialysis patients. Br. J. Nutr. 123(11), 1269\u20131276 (2020).","journal-title":"Br. J. Nutr."},{"issue":"2","key":"13149_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.hkjn.2015.08.001","volume":"17","author":"AS-M Choy","year":"2015","unstructured":"Choy, A.S.-M. et al. Weight change during the first year of peritoneal dialysis: Risk factors and prognostic implications. Hong Kong J. Nephrol. 17(2), 28\u201335 (2015).","journal-title":"Hong Kong J. Nephrol."},{"key":"13149_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/nu8110702","volume":"8","author":"D Keane","year":"2016","unstructured":"Keane, D. et al. Changes in body composition in the two years after initiation of haemodialysis: A retrospective cohort study. Nutrients 8, 11 (2016).","journal-title":"Nutrients"},{"key":"13149_CR4","first-page":"9","volume":"12","author":"WJ Visser","year":"2020","unstructured":"Visser, W. J., Egmond, A., Timman, R., Severs, D. & Hoorn, E. J. Risk factors for muscle loss in hemodialysis patients with high comorbidity. Nutrients 12, 9 (2020).","journal-title":"Nutrients"},{"issue":"2","key":"13149_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/ajcn\/83.2.202","volume":"83","author":"K Kalantar-Zadeh","year":"2006","unstructured":"Kalantar-Zadeh, K. et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am. J. Clin. Nutr. 83(2), 202\u2013210 (2006).","journal-title":"Am. J. Clin. Nutr."},{"issue":"10","key":"13149_CR6","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.2215\/CJN.10951012","volume":"8","author":"I Cabezas-Rodriguez","year":"2013","unstructured":"Cabezas-Rodriguez, I. et al. Influence of body mass index on the association of weight changes with mortality in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 8(10), 1725\u20131733 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"13149_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.xkme.2020.12.008","volume":"3","author":"K Wang","year":"2021","unstructured":"Wang, K., Zelnick, L. R., Chertow, G. M., Himmelfarb, J. & Bansal, N. Body composition changes following dialysis initiation and cardiovascular and mortality outcomes in CRIC (chronic renal insufficiency cohort): A bioimpedance analysis substudy. Kidney Med. 3(3), 327\u2013334 (2021).","journal-title":"Kidney Med."},{"issue":"1","key":"13149_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.clnu.2020.04.034","volume":"40","author":"C Kim","year":"2021","unstructured":"Kim, C., Kim, J. K., Lee, H. S., Kim, S. G. & Song, Y. R. Longitudinal changes in body composition are associated with all-cause mortality in patients on peritoneal dialysis. Clin. Nutr. 40(1), 120\u2013126 (2021).","journal-title":"Clin. Nutr."},{"key":"13149_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.abst.2020.09.001","volume":"2","author":"WH Than","year":"2020","unstructured":"Than, W. H., Chan, G.C.-K., Ng, J.K.-C. & Szeto, C.-C. The role of obesity on chronic kidney disease development, progression, and cardiovascular complications. Adv. Biomark. Sci. Technol. 2, 24\u201334 (2020).","journal-title":"Adv. Biomark. Sci. Technol."},{"issue":"7","key":"13149_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103475","volume":"9","author":"CC Pelletier","year":"2014","unstructured":"Pelletier, C. C. et al. The relationship between renal function and plasma concentration of the cachectic factor zinc-alpha2-glycoprotein (ZAG) in adult patients with chronic kidney disease. PLoS ONE 9(7), e103475 (2014).","journal-title":"PLoS ONE"},{"issue":"5","key":"13149_CR11","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/ki.2013.9","volume":"83","author":"CC Pelletier","year":"2013","unstructured":"Pelletier, C. C. et al. White adipose tissue overproduces the lipid-mobilizing factor zinc alpha2-glycoprotein in chronic kidney disease. Kidney Int. 83(5), 878\u2013886 (2013).","journal-title":"Kidney Int."},{"issue":"5","key":"13149_CR12","first-page":"669","volume":"60","author":"A Philipp","year":"2011","unstructured":"Philipp, A. et al. Serum levels of the adipokine zinc-alpha2-glycoprotein are increased in chronic hemodialysis. Metabolism 60(5), 669\u2013672 (2011).","journal-title":"Metabolism"},{"key":"13149_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/nu13062023","volume":"13","author":"M Banaszak","year":"2021","unstructured":"Banaszak, M., Gorna, I. & Przyslawski, J. Zinc and the innovative zinc-alpha2-glycoprotein adipokine play an important role in lipid metabolism: A critical review. Nutrients 13, 6 (2021).","journal-title":"Nutrients"},{"issue":"12","key":"13149_CR14","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1210\/jc.2009-0764","volume":"94","author":"V Ceperuelo-Mallafre","year":"2009","unstructured":"Ceperuelo-Mallafre, V. et al. Circulating and adipose tissue gene expression of zinc-alpha2-glycoprotein in obesity: Its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat. J. Clin. Endocrinol. Metab. 94(12), 5062\u20135069 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"13149_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.arcmed.2017.10.004","volume":"48","author":"MJ Hosseinzadeh-Attar","year":"2017","unstructured":"Hosseinzadeh-Attar, M. J., Mahdavi-Mazdeh, M., Yaseri, M., Zahed, N. S. & Alipoor, E. Comparative assessment of serum adipokines zinc-alpha2-glycoprotein and adipose triglyceride lipase, and cardiovascular risk factors between normal weight and obese patients with hemodialysis. Arch. Med. Res. 48(5), 459\u2013466 (2017).","journal-title":"Arch. Med. Res."},{"issue":"5","key":"13149_CR16","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.kint.2018.07.019","volume":"94","author":"A Bouchara","year":"2018","unstructured":"Bouchara, A. et al. Serum levels of the adipokine zinc-alpha2-glycoprotein (ZAG) predict mortality in hemodialysis patients. Kidney Int. 94(5), 983\u2013992 (2018).","journal-title":"Kidney Int."},{"key":"13149_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1471-2369-14-145","volume":"14","author":"I Sorensen-Zender","year":"2013","unstructured":"Sorensen-Zender, I. et al. Zinc-alpha2-glycoprotein in patients with acute and chronic kidney disease. BMC Nephrol. 14, 145 (2013).","journal-title":"BMC Nephrol."},{"issue":"3","key":"13149_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1365-2265.2009.03658.x","volume":"72","author":"T Mracek","year":"2010","unstructured":"Mracek, T. et al. The adipokine zinc-alpha2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity. Clin. Endocrinol. (Oxf). 72(3), 334\u2013341 (2010).","journal-title":"Clin. Endocrinol. (Oxf)."},{"issue":"4","key":"13149_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3747\/pdi.2013.00066","volume":"34","author":"BC Kwan","year":"2014","unstructured":"Kwan, B. C. et al. Bioimpedance spectroscopy for the detection of fluid overload in Chinese peritoneal dialysis patients. Perit. Dial. Int. 34(4), 409\u2013416 (2014).","journal-title":"Perit. Dial. Int."},{"key":"13149_CR20","first-page":"2","volume":"2","author":"GC-K Chan","year":"2021","unstructured":"Chan, G.C.-K. et al. Adipose expression of miR-130b and miR-17\u20135p with wasting, cardiovascular event and mortality in advanced chronic kidney disease patients. Nephrol. Dial. Transplant. 2, 2 (2021).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"13149_CR21","doi-asserted-by":"publisher","first-page":"210","DOI":"10.5770\/cgj.23.463","volume":"23","author":"K Rockwood","year":"2020","unstructured":"Rockwood, K. & Theou, O. Using the clinical frailty scale in allocating scarce health care resources. Can. Geriatr. J. 23(3), 210\u2013215 (2020).","journal-title":"Can. Geriatr. J."},{"issue":"5","key":"13149_CR22","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1210\/en.2003-1336","volume":"145","author":"JN Fain","year":"2004","unstructured":"Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P. & Bahouth, S. W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145(5), 2273\u20132282 (2004).","journal-title":"Endocrinology"},{"key":"13149_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.692213","volume":"8","author":"TD Kraemer","year":"2021","unstructured":"Kraemer, T. D. et al. Changes in AZGP1 serum levels and correlation with pulse wave velocity after kidney transplantation. Front. Cardiovasc. Med. 8, 692213 (2021).","journal-title":"Front. Cardiovasc. Med."},{"issue":"9","key":"13149_CR24","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1177\/39.9.1918940","volume":"39","author":"T Tada","year":"1991","unstructured":"Tada, T. et al. Immunohistochemical localization of Zn-alpha 2-glycoprotein in normal human tissues. J. Histochem. Cytochem. 39(9), 1221\u20131226 (1991).","journal-title":"J. Histochem. Cytochem."},{"issue":"9","key":"13149_CR25","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3109\/0886022X.2012.712859","volume":"34","author":"VO Leal","year":"2012","unstructured":"Leal, V. O. et al. Zinc-alpha2-glycoprotein: Is there association between this new adipokine and body composition in hemodialysis patients?. Ren. Fail. 34(9), 1062\u20131067 (2012).","journal-title":"Ren. Fail."},{"issue":"6","key":"13149_CR26","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/ncp.10481","volume":"35","author":"AM de Abreu","year":"2020","unstructured":"de Abreu, A. M., Wilvert, L. C. & Wazlawik, E. Comparison of body mass index, skinfold thickness, and bioelectrical impedance analysis with dual-energy X-ray absorptiometry in hemodialysis patients. Nutr. Clin. Pract. 35(6), 1021\u20131028 (2020).","journal-title":"Nutr. Clin. Pract."},{"issue":"3","key":"13149_CR27","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1053\/j.jrn.2019.08.007","volume":"30","author":"AK Dubey","year":"2020","unstructured":"Dubey, A. K. et al. Reliability of anthropometry-based equations compared to dual energy absorptiometry for assessing body composition in predialysis chronic kidney disease\u2014A longitudinal study. J. Ren. Nutr. 30(3), 216\u2013222 (2020).","journal-title":"J. Ren. Nutr."},{"issue":"3 Suppl 1","key":"13149_CR28","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","volume":"76","author":"TA Ikizler","year":"2020","unstructured":"Ikizler, T. A. et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am. J. Kidney Dis. 76(3 Suppl 1), S1\u2013S107 (2020).","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"13149_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.krcp.2015.12.007","volume":"35","author":"WK Lo","year":"2016","unstructured":"Lo, W. K. Metabolic syndrome and obesity in peritoneal dialysis. Kidney Res. Clin. Pract. 35(1), 10\u201314 (2016).","journal-title":"Kidney Res. Clin. Pract."},{"issue":"1","key":"13149_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3747\/pdi.2009.00131","volume":"31","author":"SJ Choi","year":"2011","unstructured":"Choi, S. J. et al. Changes in body fat mass in patients after starting peritoneal dialysis. Perit. Dial. Int. 31(1), 67\u201373 (2011).","journal-title":"Perit. Dial. Int."},{"key":"13149_CR31","first-page":"2","volume":"2","author":"WH Than","year":"2021","unstructured":"Than, W. H. et al. The change in the prevalence of obesity and new-onset diabetes in Chinese peritoneal dialysis patients over 25 years. Clin. Kidney J. 2, 2 (2021).","journal-title":"Clin. Kidney J."},{"key":"13149_CR32","first-page":"10","volume":"9","author":"X Huang","year":"2017","unstructured":"Huang, X. et al. Chronic high dose zinc supplementation induces visceral adipose tissue hypertrophy without altering body weight in mice. Nutrients 9, 10 (2017).","journal-title":"Nutrients"},{"issue":"1","key":"13149_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/ije\/dyh299","volume":"34","author":"AG Barnett","year":"2005","unstructured":"Barnett, A. G., van der Pols, J. C. & Dobson, A. J. Regression to the mean: What it is and how to deal with it. Int. J. Epidemiol. 34(1), 215\u2013220 (2005).","journal-title":"Int. J. Epidemiol."},{"key":"13149_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/309570","volume":"2014","author":"O Addison","year":"2014","unstructured":"Addison, O., Marcus, R. L., Lastayo, P. C. & Ryan, A. S. Intermuscular fat: A review of the consequences and causes. Int. J. Endocrinol. 2014, 309570 (2014).","journal-title":"Int. J. Endocrinol."},{"issue":"6039","key":"13149_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1126\/science.1198973","volume":"333","author":"SK Das","year":"2011","unstructured":"Das, S. K. et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science 333(6039), 233\u2013238 (2011).","journal-title":"Science"},{"issue":"11","key":"13149_CR36","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1681\/ASN.2014050485","volume":"26","author":"I Sorensen-Zender","year":"2015","unstructured":"Sorensen-Zender, I. et al. Zinc-alpha2-glycoprotein exerts antifibrotic effects in kidney and heart. J. Am. Soc. Nephrol. 26(11), 2659\u20132668 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5\u20136","key":"13149_CR37","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.cca.2011.12.002","volume":"413","author":"VO Leal","year":"2012","unstructured":"Leal, V. O. et al. Is zinc-alpha2-glycoprotein a cardiovascular protective factor for patients undergoing hemodialysis?. Clin. Chim. Acta. 413(5\u20136), 616\u2013619 (2012).","journal-title":"Clin. Chim. Acta."},{"key":"13149_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fendo.2019.00197","volume":"10","author":"M Liu","year":"2019","unstructured":"Liu, M. et al. Serum zinc-alpha2-glycoprotein levels were decreased in patients with premature coronary artery disease. Front. Endocrinol. (Lausanne). 10, 197 (2019).","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"4","key":"13149_CR39","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.bbalip.2011.12.003","volume":"1821","author":"ST Russell","year":"2012","unstructured":"Russell, S. T. & Tisdale, M. J. Role of beta-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-alpha2-glycoprotien (ZAG). Biochim. Biophys. Acta. 1821(4), 590\u2013599 (2012).","journal-title":"Biochim. Biophys. Acta."},{"issue":"1","key":"13149_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.kint.2017.02.013","volume":"92","author":"H Noh","year":"2017","unstructured":"Noh, H. et al. Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications. Kidney Int. 92(1), 101\u2013113 (2017).","journal-title":"Kidney Int."},{"issue":"6","key":"13149_CR41","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/sdi.12834","volume":"32","author":"P Kittiskulnam","year":"2019","unstructured":"Kittiskulnam, P. & Johansen, K. L. The obesity paradox: A further consideration in dialysis patients. Semin. Dial. 32(6), 485\u2013489 (2019).","journal-title":"Semin. Dial."},{"issue":"9","key":"13149_CR42","first-page":"1549","volume":"32","author":"TI Chang","year":"2017","unstructured":"Chang, T. I. et al. Association of body weight changes with mortality in incident hemodialysis patients. Nephrol. Dial. Transplant. 32(9), 1549\u20131558 (2017).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"13149_CR43","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.kint.2018.08.010","volume":"94","author":"R Schmitt","year":"2018","unstructured":"Schmitt, R. ZAG-a novel biomarker for cardiovascular risk in ESRD patients?. Kidney Int. 94(5), 858\u2013860 (2018).","journal-title":"Kidney Int."},{"issue":"1","key":"13149_CR44","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12882-020-01994-4","volume":"21","author":"GC Chan","year":"2020","unstructured":"Chan, G. C. et al. Depression does not predict clinical outcome of Chinese peritoneal dialysis patients after adjusting for the degree of frailty. BMC Nephrol. 21(1), 329 (2020).","journal-title":"BMC Nephrol."},{"issue":"7","key":"13149_CR45","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.2215\/CJN.08550814","volume":"10","author":"D Marcelli","year":"2015","unstructured":"Marcelli, D. et al. Body composition and survival in dialysis patients: Results from an international cohort study. Clin. J. Am. Soc. Nephrol. 10(7), 1192\u20131200 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"13149_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1471-2253-14-124","volume":"14","author":"ID Welters","year":"2014","unstructured":"Welters, I. D., Bing, C., Ding, C., Leuwer, M. & Hall, A. M. Circulating anti-inflammatory adipokines High Molecular Weight Adiponectin and Zinc-alpha2-glycoprotein (ZAG) are inhibited in early sepsis, but increase with clinical recovery: A pilot study. BMC Anesthesiol. 14, 124 (2014).","journal-title":"BMC Anesthesiol."},{"issue":"1","key":"13149_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.endinu.2016.10.002","volume":"64","author":"X Escote","year":"2017","unstructured":"Escote, X. et al. Zinc alpha-2 glycoprotein is overproduced in Cushing\u2019s syndrome. Endocrinol. Diabetes Nutr. 64(1), 26\u201333 (2017).","journal-title":"Endocrinol. Diabetes Nutr."},{"issue":"10","key":"13149_CR48","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1055\/a-1186-0649","volume":"52","author":"W Zhang","year":"2020","unstructured":"Zhang, W. et al. Zinc-alpha2-glycoprotein knockout influenced genes expression profile in adipose tissue and decreased the lipid mobilizing after dexamethasone treatment in mice. Horm. Metab. Res. 52(10), 755\u2013763 (2020).","journal-title":"Horm. Metab. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13149-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13149-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13149-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:52:23Z","timestamp":1669348343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13149-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13149"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13149-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"assertion":[{"value":"1 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9087"}}